All News Intellipharmaceutics International Inc.

Equities

IPCI.H

CA4581733090

Delayed Toronto S.E. Other stock markets 12:00:00 2024-03-21 pm EDT			5-day change	1st Jan Change
0.08 ^CAD	-.--%		-11.11%	+6.67%

Jan. 03	IntelliPharmaCeutics International Receives Conditional Approval For TSXV Listing	MT
2023	Intellipharmaceutics International Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Canadian Investment Regulatory Organization Trading Halt - IPCI	Mar. 06	AQ
IntelliPharmaCeutics International Receives Conditional Approval For TSXV Listing	Jan. 03	MT
Intellipharmaceutics: Fiscal Q3 Earnings Snapshot	23-10-16	AQ
Intellipharmaceutics International : MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED AUGUST 31, 2023 - Form 6-K	23-10-16	PU
Intellipharmaceutics International Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023	23-10-16	CI
Intellipharmaceutics International : Reports Director Election Results - Form 6-K	23-10-06	PU
Intellipharmaceutics International : Appointment of Proxyholder - Form 6-K	23-10-06	PU
Intellipharmaceutics International : MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS - Form 6-K	23-09-26	PU
Intellipharmaceutics Announces Second Quarter 2023 Results	23-07-17	AQ
Intellipharmaceutics International Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023	23-07-14	CI
Intellipharmaceutics: Fiscal Q2 Earnings Snapshot	23-07-14	AQ
IntelliPharmaCeutics International Fiscal Q2 Loss Narrows on Higher Revenue	23-07-14	MT
Canadian Investment Regulatory Organization Trade Resumption - IPCI	23-06-08	AQ
Intellipharmaceutics: Fiscal Q4 Earnings Snapshot	23-06-06	AQ
Intellipharmaceutics: Fiscal Q1 Earnings Snapshot	23-06-06	AQ
Intellipharmaceutics International Narrows Fiscal Q1 Loss, Revenue Rises	23-06-06	MT
Intellipharmaceutics International Inc. Brief: Recorded net loss for Q1 of US$355,738 or $0.01 per common shar	23-06-06	MT
Intellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 Results	23-06-06	AQ
Intellipharmaceutics International Inc. Auditor Raises 'Going Concern' Doubt	23-06-04	CI
Intellipharmaceutics International Inc. Reports Earnings Results for the First Quarter Ended February 28, 2023	23-06-04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Intellipharmaceutics International Inc.

Equities

IPCI.H

CA4581733090

All News

Filters